Early Surgery Bleeding Study in Patients Using NOAC for Femoral Neck Fracture Monitoring NOAC Blood Levels and Bleeding Outcomes During Surgery

What this Trial Is About

Researchers are studying patients with femoral neck fractures who are taking NOAC novel oral anticoagulants therapy to see if they can safely undergo surgery sooner than the usual 24-hour wait period. The study aims to monitor bleeding during surgery and measure NOAC drug levels in the blood. It compares patients who have early surgery to those who have surgery later to evaluate bleeding risks. The research involves a procedure called femoral neck closed reduction internal fixation CRIF performed while patients are still under NOAC therapy. There are no special interventions beyond taking blood tests to measure drug levels. Two study groups include those receiving early surgery and those undergoing later surgery. Participants will be adults over 18 years with femoral neck fractures on NOAC therapy who can give informed consent. Researchers will monitor bleeding over 30 days following surgery and measure drug levels in the blood. The study is observational, led by Meir Hospital in Israel, and does not involve healthy volunteers. The total study duration and specific visit schedules are not detailed but focus on surgery outcomes and safety.

Monitoring Bleeding of Patients Using NOAC Anticoagulation Therapy in Proximal Femoral Fracture Internal Fixation Surgery Without Waiting. We Measure Bleeding in Surgery and the Levels of Noac Drug in Blood. We Will Try to Compare to Regular Pateints Later